These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 35170372)

  • 21. Exosomal circ_PIP5K1A regulates the progression of non-small cell lung cancer and cisplatin sensitivity by miR-101/ABCC1 axis.
    Shao N; Song L; Sun X
    Mol Cell Biochem; 2021 Jun; 476(6):2253-2267. PubMed ID: 33570734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
    Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W
    Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The malignant property of circHIPK2 for angiogenesis and chemoresistance in non-small cell lung cancer.
    Ren M; Song X; Niu J; Tang G; Sun Z; Li Y; Kong F
    Exp Cell Res; 2022 Oct; 419(2):113276. PubMed ID: 35863454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circ-CUL2/microRNA-888-5p/RB1CC1 axis participates in cisplatin resistance in NSCLC via repressing cell advancement.
    Chen H; Li F; Xue Q
    Bioengineered; 2022 Feb; 13(2):2828-2840. PubMed ID: 35068326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circular RNA hsa_circ_0096157 contributes to cisplatin resistance by proliferation, cell cycle progression, and suppressing apoptosis of non-small-cell lung carcinoma cells.
    Lu H; Xie X; Wang K; Chen Q; Cai S; Liu D; Luo J; Kong J
    Mol Cell Biochem; 2020 Dec; 475(1-2):63-77. PubMed ID: 32767026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circ_0072083 interference enhances growth-inhibiting effects of cisplatin in non-small-cell lung cancer cells via miR-545-3p/CBLL1 axis.
    Li H; Liu F; Qin W
    Cancer Cell Int; 2020; 20():78. PubMed ID: 32190002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circular RNA circ_ASAP2 regulates drug sensitivity and functional behaviors of cisplatin-resistant gastric cancer cells by the miR-330-3p/NT5E axis.
    Sun Y; Ma J; Lin J; Sun D; Song P; Shi L; Li H; Wang R; Wang Z; Liu S
    Anticancer Drugs; 2021 Oct; 32(9):950-961. PubMed ID: 34016832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circular RNA hsa_circ_0000277 promotes tumor progression and DDP resistance in esophageal squamous cell carcinoma.
    Cheng J; Zhang R; Yan M; Li Y
    BMC Cancer; 2022 Mar; 22(1):238. PubMed ID: 35241028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circ_0074027 contributes to non-small cell lung cancer progression through positively modulating RHOA via sequestering miR-2467-3p.
    Duan Z; Wei S; Liu Y
    J Bioenerg Biomembr; 2021 Apr; 53(2):223-233. PubMed ID: 33687619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3/SOX2 axis.
    Xie H; Yao J; Wang Y; Ni B
    Drug Deliv; 2022 Dec; 29(1):1257-1271. PubMed ID: 35467477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circ_0001821 knockdown suppresses growth, metastasis, and TAX resistance of non-small-cell lung cancer cells by regulating the miR-526b-5p/GRK5 axis.
    Liu Y; Li C; Liu H; Wang J
    Pharmacol Res Perspect; 2021 Aug; 9(4):e00812. PubMed ID: 34219377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circ_0011292 Enhances Paclitaxel Resistance in Non-Small Cell Lung Cancer by Regulating miR-379-5p/TRIM65 Axis.
    Guo C; Wang H; Jiang H; Qiao L; Wang X
    Cancer Biother Radiopharm; 2022 Mar; 37(2):84-95. PubMed ID: 32833503
    [No Abstract]   [Full Text] [Related]  

  • 33. Bufalin inhibits the malignant development of non-small cell lung cancer by mediating the circ_0046264/miR-522-3p axis.
    Jin J; Yao Z; Qin H; Wang K; Xin X
    Biotechnol Lett; 2021 Jun; 43(6):1229-1240. PubMed ID: 33534015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-186-5p targeting SIX1 inhibits cisplatin resistance in non-small-cell lung cancer cells (NSCLCs).
    Liu X; Zhou X; Chen Y; Huang Y; He J; Luo H
    Neoplasma; 2020 Jan; 67(1):147-157. PubMed ID: 31686523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis.
    Ge P; Cao L; Zheng M; Yao Y; Wang W; Chen X
    Exp Mol Pathol; 2021 Jun; 120():104633. PubMed ID: 33753110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circular RNA hsa_circ_0068252 Functions in Cisplatin Resistance and Immune Response via miR-1304-5p/PD-L1 Axis in Non-Small Cell Lung Cancer.
    Li J; Xu J; Wu G; Ren Y; Wang X; Zhang Q
    Chemotherapy; 2022; 67(4):223-233. PubMed ID: 35649347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circular RNA circ_0003028 contributes to tumorigenesis by regulating GOT2 via miR-1298-5p in non-small cell lung cancer.
    Guan H; Sun C; Gu Y; Li J; Ji J; Zhu Y
    Bioengineered; 2021 Dec; 12(1):2326-2340. PubMed ID: 34077306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circular RNA circ_0008450 regulates the proliferation, migration, invasion, apoptosis and chemosensitivity of CDDP-resistant nasopharyngeal carcinoma cells by the miR-338-3p/SMAD5 axis.
    Liu L; Lu B; Li Y
    Anticancer Drugs; 2022 Jan; 33(1):e260-e272. PubMed ID: 34387609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circ_0074027 contributes to the progression of non-small cell lung cancer via microRNA-362-3p/clathrin heavy chain axis.
    Jiang Z; Yin J; Peng G; Long X
    Anticancer Drugs; 2021 Jan; 32(1):1-10. PubMed ID: 32932275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circular RNA circ_0010235 sponges miR-338-3p to play oncogenic role in proliferation, migration and invasion of non-small-cell lung cancer cells through modulating KIF2A.
    Zhu Y; Ma C; Lv A; Kou C
    Ann Med; 2021 Dec; 53(1):693-706. PubMed ID: 34024242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.